Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty

BACKGROUND: The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gillette, Blake P., DeSimone, Lori J., Trousdale, Robert T., Pagnano, Mark W., Sierra, Rafael J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer-Verlag 2012
Materias:
Symposium: Papers Presented at the Annual Meetings of the Knee Society
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528901/
https://ncbi.nlm.nih.gov/pubmed/22814857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-012-2488-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares